Operating Sales Margin: ImmunityBio Inc (IBRX)

Corporate company logo of NantKwest (IBRX)

The commercial launch of a unique cancer therapy provides ImmunityBio, Inc. (IBRX) with significant pricing power. The operating profit margin exhibits local dynamics, with the metric currently fixed at -150.20. Leadership in combating bladder tumors through T-cell activation is complemented by pipeline diversification into vaccines, which minimizes regulatory risks and expands the company's global market presence.

IBRX: immunitybio.com Operating Profit Rate 07/04/2022 - 11/19/2026

ImmunityBio, Inc. - analytical breakdowns and key metrics (IBRX)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Basic company analysis:IBRX, ImmunityBio
Core merchandise of NantKwest

Operating margin measures the efficiency of profit generation from core business processes before accounting for financial obligations and taxes, reflecting a company's actual ability to convert revenue into operating income. An analysis of the operating margin spread for ImmunityBio, Inc. (IBRX) demonstrates how the commercialization of its unique IL-15 therapy and patent protection of NK-cell activation mechanisms are transforming the cost structure into a sustainable competitive advantage, confirming the fundamental strength of the business.

Who ImmunityBio, Inc. competes with

Operating Sales Margin IMCR|JANX - Operating Profitability Margin|Operating Sales Margin RCUS (Arcus Bio)|Operating Profit Ratio ZYME|Operating Margin TNGX (Tango Therapeutics, Inc.)|Operating Profit Rate IOVA|immatics.com - Operating Margin|Operating Return on Sales Xencor Inc.|Compass Therapeutics (CMPX) - Operating Profitability|Replimune Group, Inc. - Operating Profit Rate|LYEL (lyell.com) - Operating Margin|Operating Margin Innate Pharma SA|Operating Profitability pyxisoncology.com (PYXS)|CGEN: Operating Profit Margin|IO Biotech Inc - Operating Sales Margin|sutrobio.com (STRO) - Operating Return on Sales|INKT - Operating Profitability|werewolftx.com (HOWL) - Operating Sales Margin|Immix (IMMX) - Operating Profitability|ALXO (ALX Oncology Holdings) - Operating Profitability|Operating Sales Margin CUE|PDS Biotechnology Corporation (PDSB) - Profitability of Operations|Operating Profitability Sonnet BioTherapeutics Holdings Inc. (SONN)|Operating Margin MAIA Biotechnology Inc (MAIA)|Operating Profitability Liminatus Pharma LIMN|Operating Profit Rate LVTX|NXTC: Operating Sales Margin|leaptx.com - Operating Profit Ratio|INTS: Operating Margin|Sensei Biotherapeutics Inc - Operating Profit Rate|Operating Sales Margin TOVX|Return on Sales by Operating Profit GRTS (Gritstone bio, Inc.)|Operating Sales Margin KA (kinetabio.com)|NEXI - Operating Return on Sales|Turnstone Biologics - Operating Sales Margin|Profitability of Operations Vaccinex Inc. (VCNX)|harpoontx.com - Operating Margin